Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study. Issue 11 (6th November 2020)

• Record Type: Journal Article
• Authors: Lu, Linbin; Su, Zhimin; Zheng, Peichan; Wu, Zhixian; Zhang, Yan; He, Huimin; Liu, Jingnan; Lin, Shan; Chen, Xiong
• Is Part Of: BMJ open. Volume 10:Issue 11(2020)
• Publication Date: 2020-11-06
• Subjects: oncogenes -- hepatobiliary tumours -- gastroenterology; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2020-038172
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: To explore the non-linear relationship between platelet count (PLT) and hepatocellular carcinoma (HCC) overall survival (OS). Setting: The study was done in Sun Yat-sen University Cancer Center (SYSUCC) from January 2007 to May 2012, a total of 5005 consecutive participants at SYSUCC were retrospectively reviewed, and 979 patients with Barcelona clinic liver cancer (BCLC) stage B were selected for the final analysis. Participants: A total of 979 newly diagnosed patients with HCC with BCLC stage B were identified for the secondary analysis. Eight cases were excluded for missing data of PLT. Main outcome measures: Cox proportional hazard regression models were used to calculate multivariable-adjusted HRs and 95% CIs for HCC. The non-linear relationship was estimated through a restricted cubic spline regression, and a two-piecewise Cox proportional hazards model was further performed to calculate the threshold effect. We used multiple imputation to deal with the missing data. Results: In the multivariate analysis, Log PLT was associated with a 91% risk increase in death (HR 1.91; 1.28 to 2.85) with adjustment for gender, Child-Pugh class, age × diameter of main tumour, both lobe with lesions × number of the intrahepatic lesions, alpha-fetoprotein (<25, ≥25) and lactic dehydrogenase (<245, ≥245). We also found a U-shape relationship between PLT and HCC OS at the inflexion point of 67.6×10 9 /L. The HR was 0.12 (95% CI 0.03 to 0.52) for Log PLT≤10.83 and 3.07 (CI 1.91 to 4.92) for Log PLT>10.83 after adjusting for potential confounders. The core results were consistent with those from the sensitivity analysis. Besides, a significantly higher hazard risk was found in the patients with age <55, both lobes with lesions, tumour diameter >50, haemoglobin ≥120 and C reactive protein >10. Conclusion: PLT was nonlinearly associated with HCC OS.